CD279-PC7 (クローン: PD1.3, 50テスト)

CD279-PC7 (クローン: PD1.3, 50テスト)

Product no. A78885

Learn more about this product on Beckman.com
CD279-PC7 (クローン: PD1.3, 50テスト)
Target SpeciesHuman
SpecificityCD279
Other NamesCD279, PD-1
FluorochromePC7
Regulatory StatusASR
Size0.5 mL
FormatLiquid
Flow Product LineIOTest
ClonePD1.3
IsotypeIgG2b Mouse
Clone DescriptionThe PD1.3 monoclonal antibody recognizes T cells, activated CD4 and CD8 positive cells and activated B cells. This antibody has been assigned to the CD279 cluster of differentiation during the 8th HLDA Workshop on Human Leukocyte Differentiation Antigens, held in Adelaide, Australia, in 2004.
Volume0.5 mL
Additional information and DisclaimersCy® and CyDye® are registered trademarks of Cytiva.
CD279-PC7 (クローン: PD1.3, 50テスト)
© Beckman Coulter, Inc. All rights reserved.

Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES. PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS The listed regulatory status for products correspond to one of the below: IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use." ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagent. Analytical and performance characteristics are not established." CE-IVD, CE: Products intended for in vitro diagnostic use and conforming to the In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. (Note: Devices may be CE marked to other directives.) RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures." LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only." No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.